Open- | Close- |
Vol / Avg.0 / 1.915M | Mkt Cap842.859M |
Day Range- - - | 52 Wk Range2.945 - 4.650 |
ADMA Biologics Stock (NASDAQ: ADMA) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 1.915M | Mkt Cap842.859M |
Day Range- - - | 52 Wk Range2.945 - 4.650 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.010 | 0.010 | 0.0200 | ||||
REV | 62.120M | 67.275M | 5.155M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.020 | -0.030 | -0.0100 | ||||
REV | 55.500M | 60.123M | 4.623M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-17 | HC Wainwright & Co. | Raghuram Selvaraju | Reiterates | BuyBuy | Maintains | - | 5.00 |
2023-08-10 | Cantor Fitzgerald | Kristen Kluska | Maintains | OverweightOverweight | Raises | 5.00 | 6.00 |
2023-08-10 | Raymond James | Elliot Wilbur | Maintains | Strong BuyStrong Buy | Raises | 5.00 | 6.00 |
2023-08-10 | HC Wainwright & Co. | Raghuram Selvaraju | Maintains | BuyBuy | Raises | 4.50 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ADMA | ADMA Biologics | 0% | 842.9M |
VALN | Valneva | 6.58% | 865.3M |
ZNTL | Zentalis Pharma | 0% | 750.8M |
AMAM | Ambrx Biopharma | 2.39% | 757.8M |
IMTX | Immatics | 0% | 728M |
You can purchase shares of ADMA Biologics (NASDAQ: ADMA) through any online brokerage.
Other companies in ADMA Biologics’s space includes: Valneva (NASDAQ:VALN), Zentalis Pharma (NASDAQ:ZNTL), Ambrx Biopharma (NASDAQ:AMAM), Immatics (NASDAQ:IMTX) and Tango Therapeutics (NASDAQ:TNGX).
The latest price target for ADMA Biologics (NASDAQ: ADMA) was reported by HC Wainwright & Co. on Friday, November 17, 2023. The analyst firm set a price target for 5.00 expecting ADMA to rise to within 12 months (a possible 34.05% upside). 7 analyst firms have reported ratings in the last year.
The stock price for ADMA Biologics (NASDAQ: ADMA) is $3.73 last updated November 29, 2023 at 9:00 PM UTC.
There is no dividend information for ADMA Biologics.
ADMA Biologics’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for ADMA Biologics.
ADMA Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.